GL1X · GenesisL1 explorer

Research workbench

Viability of a drug-resistant HIV-1 protease variant: structural insights for better anti-viral therapy

Analyse Viability of a drug-resistant HIV-1 protease variant: structural insights for… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1N49
Type
protein
Length
396 residues
Chains
4
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Protease
EC
3.4.23.16
UniProt
P03369
Ligands
RIT
Pockets
4 · best druggability 0.67

Structure

x-ray diffraction · 1 distinct chain · 4% helix, 55% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, B, C, DProtease (EC 3.4.23.16)protein994% helix, 55% strandP03369

Ligands and binding sites

  • RIT · Ritonavir · ligand · 2 copies · chains A, B, C, D

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15490.670.7860RIT
23880.670.8040RIT
3980.430.7820empty
41230.390.7420empty

Interfaces

5 interfaces between chains.

  • C–D · 1773 Ų buried · 36 hydrogen bonds · protein-protein
  • A–B · 1737 Ų buried · 34 hydrogen bonds · protein-protein
  • B–D · 231 Ų buried · 0 hydrogen bonds · protein-protein
  • A–C · 141 Ų buried · 0 hydrogen bonds · protein-protein
  • B–C · 61 Ų buried · 0 hydrogen bonds · protein-protein

Compared structures

  • 1N49 · Viability of a Drug-Resistant HIV-1 Protease Variant: Structural Insights for Better… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.